These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 4414187

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Double blind controlled trial of deanol in tardive dyskinesia.
    George J, Pridmore S, Aldous D.
    Aust N Z J Psychiatry; 1981 Mar; 15(1):68-71. PubMed ID: 6942835
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.
    de Montigny C, Chouinard G, Annable L.
    Psychopharmacology (Berl); 1979 Nov; 65(3):219-23. PubMed ID: 117492
    [Abstract] [Full Text] [Related]

  • 25. Deanol in the treatment of tardive dyskinesia.
    Simpson GM, Voitashevsky A, Young MA, Lee JH.
    Psychopharmacology (Berl); 1977 May 09; 52(3):257-61. PubMed ID: 406628
    [Abstract] [Full Text] [Related]

  • 26. Deanol acetamidobenzoate treatment in choreiform movement disorders.
    Tarsy D, Bralower M.
    Arch Neurol; 1977 Dec 09; 34(12):756-8. PubMed ID: 145212
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.
    Jus A, Villeneuve A, Gautier J, Jus K, Villeneuve C, Pires P, Villeneuve R.
    Neuropsychobiology; 1978 Dec 09; 4(3):140-9. PubMed ID: 340975
    [Abstract] [Full Text] [Related]

  • 31. The effect of dimethylaminoethanol (deanol) on amphetamine-induced stereotyped behavior (AISB).
    Weiner WJ, Kanapa DJ, Klawans HL.
    Life Sci; 1976 Nov 01; 19(9):1371-5. PubMed ID: 1033446
    [No Abstract] [Full Text] [Related]

  • 32. Double-blind evaluation of deanol in tardive dyskinesia.
    Penovich P, Morgan JP, Kerzner B, Karch F, Goldblatt D.
    JAMA; 1978 May 12; 239(19):1997-8. PubMed ID: 347112
    [Abstract] [Full Text] [Related]

  • 33. Letter: Dimethylaminoethanol ineffective in Huntington's disease.
    Reibling A, Reyes P, Jameson HD.
    N Engl J Med; 1975 Oct 02; 293(14):724. PubMed ID: 125853
    [No Abstract] [Full Text] [Related]

  • 34. 2-dimethylaminoethanol (Deanol) in Huntington's chorea.
    Caraceni TA, Girotti F, Celano I, Parati E, Balboni L.
    J Neurol Neurosurg Psychiatry; 1978 Dec 02; 41(12):1114-8. PubMed ID: 153384
    [Abstract] [Full Text] [Related]

  • 35. Tardive dyskinesia: are there subtypes?
    Casey DE.
    N Engl J Med; 1976 Nov 04; 295(19):1078. PubMed ID: 972665
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cholinergic influences in tardive dyskinesia.
    Tamminga CA, Smith RC, Ericksen SE, Chang S, Davis JM.
    Am J Psychiatry; 1977 Jul 04; 134(7):769-74. PubMed ID: 869054
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Persistent tardive dyskinesia.
    Carruthers SG.
    Br Med J; 1971 Sep 04; 3(5774):572. PubMed ID: 5106314
    [No Abstract] [Full Text] [Related]

  • 40. Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.
    Paulson GW, Rizvi CA, Crane GE.
    Clin Pediatr (Phila); 1975 Oct 04; 14(10):953-5. PubMed ID: 1100296
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.